252 related articles for article (PubMed ID: 32959937)
21. The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway.
Liu XX; Bao QX; Li YM; Zhang YH
Bioengineered; 2021 Dec; 12(1):3322-3335. PubMed ID: 34224325
[TBL] [Abstract][Full Text] [Related]
22. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
Zhu J; Han S
Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
[TBL] [Abstract][Full Text] [Related]
23. DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.
Liu Z; Wu M; Shi H; Huang C; Luo S; Song X
J Cell Biochem; 2019 Jun; 120(6):10228-10238. PubMed ID: 30582201
[TBL] [Abstract][Full Text] [Related]
24. DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p.
Wu N; Song H; Ren Y; Tao S; Li S
Cell Biochem Funct; 2020 Oct; 38(7):870-879. PubMed ID: 32283566
[TBL] [Abstract][Full Text] [Related]
25. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
26. REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e/DKK1/Wnt/β-catenin signaling pathway.
Luan Y; Xie B; Wei W
J Cell Biochem; 2021 Jan; 122(1):16-28. PubMed ID: 32965043
[TBL] [Abstract][Full Text] [Related]
27. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
[TBL] [Abstract][Full Text] [Related]
28. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.
Zhang L; Liu SK; Song L; Yao HR
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):556-564. PubMed ID: 30831032
[TBL] [Abstract][Full Text] [Related]
29.
Wan N; Yang W; Cheng H; Wang J
Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
[No Abstract] [Full Text] [Related]
30. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
31. SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1.
Chang S; Sun L; Feng G
Biomed Pharmacother; 2019 Sep; 117():109133. PubMed ID: 31252264
[TBL] [Abstract][Full Text] [Related]
32. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
Xiong S; Song H
Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis.
Liang J; Zhang S; Wang W; Xu Y; Kawuli A; Lu J; Xiu X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31737900
[TBL] [Abstract][Full Text] [Related]
35. Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
[TBL] [Abstract][Full Text] [Related]
36. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Zhang D; Zhang Y; Sun X
Asia Pac J Clin Oncol; 2021 Jun; 17(3):253-263. PubMed ID: 33078907
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
[TBL] [Abstract][Full Text] [Related]
38. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR.
Liu C; Zhang M; Zhao J; Zhu X; Zhu L; Yan M; Zhang X; Zhang R
Cancer Biother Radiopharm; 2020 May; 35(4):292-300. PubMed ID: 32191537
[No Abstract] [Full Text] [Related]
39. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells.
Zhou X; Zhao X; Wu Z; Ma Y; Li H
Bioengineered; 2022 Apr; 13(4):10454-10466. PubMed ID: 35465835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]